CA1330425C - Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantite - Google Patents
Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantiteInfo
- Publication number
- CA1330425C CA1330425C CA000591908A CA591908A CA1330425C CA 1330425 C CA1330425 C CA 1330425C CA 000591908 A CA000591908 A CA 000591908A CA 591908 A CA591908 A CA 591908A CA 1330425 C CA1330425 C CA 1330425C
- Authority
- CA
- Canada
- Prior art keywords
- gene
- foreign gene
- foreign
- polyhedrin
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 212
- 241000701447 unidentified baculovirus Species 0.000 title claims abstract description 88
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 36
- 230000014509 gene expression Effects 0.000 title claims abstract description 30
- 101710182846 Polyhedrin Proteins 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 62
- 239000002773 nucleotide Substances 0.000 claims abstract description 57
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 55
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 44
- 241000238631 Hexapoda Species 0.000 claims abstract description 43
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims abstract description 34
- 108091081024 Start codon Proteins 0.000 claims abstract description 31
- 241000700605 Viruses Species 0.000 claims abstract description 30
- 230000005030 transcription termination Effects 0.000 claims abstract description 17
- 238000002703 mutagenesis Methods 0.000 claims abstract description 14
- 231100000350 mutagenesis Toxicity 0.000 claims abstract description 14
- 239000013598 vector Substances 0.000 claims description 49
- 238000013519 translation Methods 0.000 claims description 35
- 108020004414 DNA Proteins 0.000 claims description 26
- 238000012546 transfer Methods 0.000 claims description 23
- 101710201961 Virion infectivity factor Proteins 0.000 claims description 16
- 108020004705 Codon Proteins 0.000 claims description 14
- 101710150344 Protein Rev Proteins 0.000 claims description 12
- 101710149951 Protein Tat Proteins 0.000 claims description 11
- 108010089520 pol Gene Products Proteins 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 9
- 241001203868 Autographa californica Species 0.000 claims description 4
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 16
- 239000012530 fluid Substances 0.000 claims 2
- 241001367049 Autographa Species 0.000 claims 1
- 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 claims 1
- 108091026890 Coding region Proteins 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000014621 translational initiation Effects 0.000 abstract description 5
- 108091092195 Intron Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 51
- 239000013612 plasmid Substances 0.000 description 30
- 239000000047 product Substances 0.000 description 18
- 230000001413 cellular effect Effects 0.000 description 8
- 230000029087 digestion Effects 0.000 description 8
- 108700026220 vif Genes Proteins 0.000 description 8
- 101150059019 vif gene Proteins 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 241000256251 Spodoptera frugiperda Species 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 108700004030 rev Genes Proteins 0.000 description 7
- 101150098213 rev gene Proteins 0.000 description 7
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 208000030507 AIDS Diseases 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 108700004029 pol Genes Proteins 0.000 description 4
- 101150088264 pol gene Proteins 0.000 description 4
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 4
- 241000255789 Bombyx mori Species 0.000 description 3
- 238000011537 Coomassie blue staining Methods 0.000 description 3
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 108020005038 Terminator Codon Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 241000212384 Bifora Species 0.000 description 2
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 description 2
- 108010061833 Integrases Proteins 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000004264 monolayer culture Methods 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 229940031626 subunit vaccine Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- ZZBAGJPKGRJIJH-UHFFFAOYSA-N 7h-purine-2-carbaldehyde Chemical compound O=CC1=NC=C2NC=NC2=N1 ZZBAGJPKGRJIJH-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 241000256248 Spodoptera Species 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 102000055277 human IL2 Human genes 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007030 peptide scission Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000591908A CA1330425C (fr) | 1989-02-23 | 1989-02-23 | Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantite |
| US07/743,357 US5858646A (en) | 1989-02-23 | 1990-02-23 | Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent |
| PCT/CA1990/000062 WO1990010230A1 (fr) | 1989-02-23 | 1990-02-23 | Polypeptide avec activite immunologique destine a servir de vaccin et/ou de reactif diagnostique |
| PCT/CA1990/000061 WO1990010078A1 (fr) | 1989-02-23 | 1990-02-23 | Systeme ameliore d'expression de baculovirus capable de produire des proteines de genes etrangers en grande quantite |
| AU51841/90A AU5184190A (en) | 1989-02-23 | 1990-02-23 | Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine |
| AU51871/90A AU5187190A (en) | 1989-02-23 | 1990-02-23 | Improved baculovirus expression system capable of producing foreign gene proteins at high levels |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000591908A CA1330425C (fr) | 1989-02-23 | 1989-02-23 | Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1330425C true CA1330425C (fr) | 1994-06-28 |
Family
ID=4139682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000591908A Expired - Fee Related CA1330425C (fr) | 1989-02-23 | 1989-02-23 | Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantite |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1330425C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022084438A1 (fr) * | 2020-10-22 | 2022-04-28 | Intervet International B.V. | Vecteur d'expression de baculovirus |
-
1989
- 1989-02-23 CA CA000591908A patent/CA1330425C/fr not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022084438A1 (fr) * | 2020-10-22 | 2022-04-28 | Intervet International B.V. | Vecteur d'expression de baculovirus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5194376A (en) | Baculovirus expression system capable of producing foreign gene proteins at high levels | |
| JP3183877B2 (ja) | 修飾バキュロウイルス、その調整方法及びそれの形質発現ベクターとしての適用 | |
| WO1990010078A1 (fr) | Systeme ameliore d'expression de baculovirus capable de produire des proteines de genes etrangers en grande quantite | |
| US5244805A (en) | Baculovirus expression vectors | |
| JP3076833B2 (ja) | 修飾されたバクロウイルス、その製造方法及び該バクロウイルスから得られる発現ベクター | |
| AU631223B2 (en) | Improved baculovirus expression vectors | |
| EP0549721B1 (fr) | Systeme d'expression de baculovirus a promoteurs multiples et production de particules defectives | |
| US4745051A (en) | Method for producing a recombinant baculovirus expression vector | |
| Fraser et al. | Assay for movement of Lepidopteran transposon IFP2 in insect cells using a baculovirus genome as a target DNA | |
| DK172401B1 (da) | Fremgangsmåder til fremstilling af rekombinante baculovirus-vektorer, vektorer fremstillet ved fremgangsmåderne, samt fremgangsmåde til fremstilling af heterologt protein under anvendelse af en baculovirus-vektor | |
| Emery et al. | The development of multiple expression vectors for high level synthesis of eukaryotic proteins: expression of LCMV-N and AcNPV polyhedrin protein by a recombinant baculovirus | |
| US6090584A (en) | Baculovirus artificial chromosomes and methods of use | |
| US5322774A (en) | Procaryotic leader sequence in recombinant baculovirus expression system | |
| US5229293A (en) | Recombinant baculovirus | |
| Li et al. | Identification of additional genes that influence baculovirus late gene expression | |
| EP0397485A1 (fr) | Vecteurs d'expression de baculovirus et leur utilisation pour l'expression de protéines étrangères dans des insectes ou cellules d'insectes | |
| US5071748A (en) | Mixed baculovirus compositions and uses thereof | |
| AU601232B2 (en) | Method for producing a heterologous protein in insect cells | |
| CN102286534B (zh) | 表达多外源基因的昆虫生物反应器及其构建方法和应用 | |
| CA1330425C (fr) | Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantite | |
| Je et al. | The use of defective Bombyx mori nucleopolyhedrovirus genomes maintained in Escherichia coli for the rapid generation of occlusion-positive and occlusion-negative expression vectors | |
| GB2228486A (en) | Improved baculovirus expression system capable of producing foreign gene proteins at high levels | |
| CA2138988A1 (fr) | Baculovirus recombinants qui contiennent un promoteur cellulaire d'insecte | |
| KR100318093B1 (ko) | 재조합돼지오제스키병바이러스 | |
| KR100562684B1 (ko) | 티미딘 키나제 선발을 이용한 돼지 오제스키병 바이러스유전자 재조합 벡터 시스템 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |